Mounjaro Wegovy Weight Loss Weight Management

Jun 27, 2026
15 MIN READ

Which is More Effective for Weight Loss: Wegovy or Mounjaro?

Wegovy and Mounjaro represent two distinct approaches to weight management through GLP-1 therapy. Understanding their mechanisms, clinical outcomes, and individual suitability helps patients make informed decisions about their treatment path.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 27, 2026
15 MIN READ

which is more effective for weight loss: wegovy or mounjaro? — PlexusDx GLP-1 education

Last reviewed: June 27, 2026

Last updated: June 27, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Both semaglutide and tirzepatide have demonstrated significant weight loss results in clinical trials, yet they work through different biological pathways. Semaglutide activates GLP-1 receptors alone, while tirzepatide activates both GLP-1 and GIP receptors simultaneously. PlexusDx offers compounded versions of both medications, allowing patients to find the approach that aligns with their body's unique peptide response profile.

How Semaglutide and Tirzepatide Work Differently

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a hormone that regulates blood sugar and appetite. When semaglutide binds to GLP-1 receptors in the brain and gut, it slows gastric emptying, increases feelings of fullness, and reduces hunger signals. This single-pathway activation has made semaglutide a foundational treatment for weight management since its approval for chronic weight loss.

Tirzepatide takes a dual-receptor approach by activating both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors. The addition of GIP receptor stimulation enhances insulin secretion, improves energy expenditure, and may reduce appetite through a second biological channel. This dual mechanism distinguishes tirzepatide as a next-generation option that addresses weight loss through multiple simultaneous pathways.

Clinical Trial Results: Weight Loss Outcomes Compared

Semaglutide trials demonstrated average weight loss of 10–15% of body weight over 68 weeks in the STEP program. Patients receiving the highest semaglutide dose (2.4 mg weekly) experienced mean weight reductions of approximately 15%, with consistent improvements in cardiovascular risk factors and metabolic health markers.

Tirzepatide trials in the SUMO program showed average weight loss of 15–22% of body weight over 72 weeks, with the highest dose (15 mg weekly) producing mean reductions exceeding 20% in some patient subgroups. Direct head-to-head comparisons suggest tirzepatide may produce slightly greater average weight loss, though individual responses vary significantly based on genetic and metabolic factors.

Genetic Factors That Influence Your Response to Each Medication

Not every patient responds identically to semaglutide or tirzepatide because genetic variations affect how efficiently your body's peptide pathways function. Key genetic markers in GLP1R and GIPR genes determine the strength of your receptors' response to these medications. PlexusDx offers the Precision Peptide Genetic Test, which analyzes variants like GLP1R rs6923761 and GIPR rs1800437 to reveal your genetic predisposition toward GLP-1 or dual-receptor activation.

Patients with certain GLP1R variants may experience robust semaglutide response and require no dose escalation, while others with reduced GLP1R receptor sensitivity benefit from tirzepatide's dual-pathway approach. The FTO rs9939609 variant also influences how your body regulates energy expenditure, affecting how well you respond to either medication's weight loss mechanism. Genetic insights from PlexusDx help guide whether semaglutide or tirzepatide aligns better with your peptide pathway strengths.

Cost, Access, and Treatment Options at PlexusDx

PlexusDx provides compounded semaglutide injections starting at $149 per month and compounded tirzepatide injections starting at $249 per month through licensed 503A compounding pharmacies. Neither medication requires insurance, membership fees, or flat per-compound pricing increases—your dose may need to go up, but your price won't. Both options are HSA and FSA eligible, making personalized weight loss therapy accessible across all 50 states.

For patients seeking to compare both medications before committing to one, PlexusDx also offers GLP-Squared Injection (a dual compound combining semaglutide and tirzepatide) starting at $249 per month. Adding the Precision Peptide Genetic Test for $99 after your first month of treatment provides actionable insights into which peptide pathway your genetics favor most strongly, enabling truly personalized therapy selection.

Side Effects and Tolerability: What to Expect

Both semaglutide and tirzepatide share common gastrointestinal side effects including nausea, vomiting, constipation, and diarrhea, particularly during dose escalation. Most patients experience mild-to-moderate symptoms that decline after the first 2–4 weeks of treatment. Tirzepatide may produce slightly higher rates of nausea in early clinical use, though individual tolerability varies widely.

Serious adverse events remain rare with both medications when prescribed and monitored appropriately. Patients with personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 should not use either medication. Working with PlexusDx ensures clear communication about your medical history, current medications, and any tolerability concerns, allowing your treatment plan to be adjusted if side effects emerge.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Which medication will help me lose more weight: semaglutide or tirzepatide?

Clinical trials suggest tirzepatide produces slightly higher average weight loss (15–22%) compared to semaglutide (10–15%), but individual results depend on your genetic peptide-pathway sensitivity, starting weight, diet, and activity level. The Precision Peptide Genetic Test from PlexusDx identifies which medication's mechanism your body is genetically predisposed to respond to most effectively.

Can I switch from semaglutide to tirzepatide if I'm not seeing results?

Yes, patients can transition between medications under appropriate medical supervision. Some individuals respond better to the dual-receptor mechanism of tirzepatide after semaglutide reaches a plateau, or vice versa. PlexusDx supports patients in exploring both options to find the medication that aligns best with their genetic profile and treatment goals.

Are PlexusDx compounded semaglutide and tirzepatide the same as brand-name Wegovy and Mounjaro?

PlexusDx medications are compounded versions of the active ingredients semaglutide and tirzepatide, prepared by licensed 503A compounding pharmacies to the same pharmaceutical standards. They contain identical active compounds but are not FDA-approved brand-name products, making them more affordable while maintaining quality and efficacy comparable to commercial equivalents.

What is the cost difference between semaglutide and tirzepatide at PlexusDx?

Compounded semaglutide injection starts at $149 per month, while compounded tirzepatide injection starts at $249 per month. Neither price increases with dose escalation, and both are available without insurance across all 50 states. HSA and FSA accounts can be used to cover either medication, improving affordability for eligible patients.

How does the Precision Peptide Genetic Test help me choose between semaglutide and tirzepatide?

The Precision Peptide Genetic Test analyzes 14 metabolic pathways and 150+ genetic insights, including GLP1R and GIPR variants that predict your receptor sensitivity to each medication. For example, strong GLP1R function may indicate excellent semaglutide response, while reduced GIPR sensitivity might suggest tirzepatide's dual activation offers superior results. This $99 test (available after your first treatment month) personalizes your therapy selection.

Which medication is safer: semaglutide or tirzepatide?

Both medications have strong safety profiles when used appropriately in eligible patients. Common side effects (nausea, constipation) are generally mild and temporary. Serious adverse events are rare but require proper screening, which PlexusDx ensures through comprehensive health history review before initiating either medication.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves